D20 | Implementation of service delivery changes to maintain access to HIV pre-exposure prophylaxis and mitigate COVID-19 in Kenya | E-poster | Adaptations of HIV treatment services during COVID-19 |
D45 | Implementing a patient satisfaction survey to identify factors responsible for missed appointments amongst PLHIVs in Nigeria | E-poster | Reduction of socio-structural barriers and stigma discrimination |
A3 | Implications of an interaction between HIV-1 Gag and the RNA interference pathway member Dicer''''''''' | E-poster | HIV biology (entry, recplicative cycle, tanscitional expression and regulation) |
C27 | Importance of accounting for ART costs saved in the long term when estimating HIV pre-exposure prophylaxis (PrEP) cost-effectiveness: a modeling study informed by the ImPrEP demonstration project | E-poster | PrEP |
D15 | Improved retention to HIV care and viral suppression among PLHIV through community home based care in Vihiga County, Kenya | E-poster | Retention in HIV services |
D42 | Improving access to ART and documentation for patients unable to reach their parent health facilities due to COVID-19 restrictions in East Central, Uganda | E-poster | Changes in policy and practice |
D1 | Improving access to HIV viral load testing in the northern regions of Cameroon | E-poster | Methodological challenges to scale up and optimization of services |
D2 | Improving health equity and ending the HIV epidemic in the United States: a distributional cost-effectiveness analysis in six cities | On-demand oral abstract session | Impact evaluation of differentiated service delivery |
D12 | Improving HIV assisted partner services by eliciting additional partners after the initial encounter | E-poster | Uptake of HIV testing |
C38 | Improving HIV Index-contacts testing (ICT) through Intimate Partner Violence (IPV)-Risk assessment questionnaire and ICT national App at selected health facilities in Haiti: challenges, mitigation and implications for the National AIDS Control Program | E-poster | Strategies to increase HIV testing and linkage to the prevention cascade |